Simvastatin decreases the level of heparin-binding protein in patients with acute lung injury View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2013-07-19

AUTHORS

Daniel F McAuley, Cecilia M O’Kane, Thelma R Craig, Murali Shyamsundar, Heiko Herwald, Karim Dib

ABSTRACT

BackgroundHeparin-binding protein is released by neutrophils during inflammation and disrupts the integrity of the alveolar and capillary endothelial barrier implicated in the development of acute lung injury and systemic organ failure. We sought to investigate whether oral administration of simvastatin to patients with acute lung injury reduces plasma heparin-binding protein levels and improves intensive care unit outcome.MethodsBlood samples were collected from patients with acute lung injury with 48 h of onset of acute lung injury (day 0), day 3, and day 7. Patients were given placebo or 80 mg simvastatin for up to 14 days. Plasma heparin-binding protein levels from patients with acute lung injury and healthy volunteers were measured by ELISA.ResultsLevels of plasma heparin-binding protein were significantly higher in patients with acute lung injury than healthy volunteers on day 0 (p = 0.011). Simvastatin 80 mg administered enterally for 14 days reduced plasma level of heparin-binding protein in patients. Reduced heparin-binding protein was associated with improved intensive care unit survival.ConclusionsA reduction in heparin-binding protein with simvastatin is a potential mechanism by which the statin may modify outcome from acute lung injury.Trial registrationCurrent controlled trials: ISRCTN70127774 More... »

PAGES

47

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/1471-2466-13-47

DOI

http://dx.doi.org/10.1186/1471-2466-13-47

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1019469490

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/23870614


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Acute Lung Injury", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Administration, Oral", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antimicrobial Cationic Peptides", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Blood Proteins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Carrier Proteins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Dose-Response Relationship, Drug", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Double-Blind Method", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hydroxymethylglutaryl-CoA Reductase Inhibitors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Intensive Care Units", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Simvastatin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Survival Rate", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Centre for Infection and Immunity, Queen\u2019s University of Belfast, Belfast, UK", 
          "id": "http://www.grid.ac/institutes/grid.4777.3", 
          "name": [
            "Regional Intensive Care Unit, Royal Victoria Hospital, Belfast, Northern Ireland, UK", 
            "Centre for Infection and Immunity, Queen\u2019s University of Belfast, Belfast, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "McAuley", 
        "givenName": "Daniel F", 
        "id": "sg:person.013052706317.18", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013052706317.18"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Centre for Infection and Immunity, Queen\u2019s University of Belfast, Belfast, UK", 
          "id": "http://www.grid.ac/institutes/grid.4777.3", 
          "name": [
            "Centre for Infection and Immunity, Queen\u2019s University of Belfast, Belfast, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "O\u2019Kane", 
        "givenName": "Cecilia M", 
        "id": "sg:person.0706061252.72", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0706061252.72"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Regional Intensive Care Unit, Royal Victoria Hospital, Belfast, Northern Ireland, UK", 
          "id": "http://www.grid.ac/institutes/grid.416232.0", 
          "name": [
            "Regional Intensive Care Unit, Royal Victoria Hospital, Belfast, Northern Ireland, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Craig", 
        "givenName": "Thelma R", 
        "id": "sg:person.01266220671.16", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01266220671.16"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Regional Intensive Care Unit, Royal Victoria Hospital, Belfast, Northern Ireland, UK", 
          "id": "http://www.grid.ac/institutes/grid.416232.0", 
          "name": [
            "Regional Intensive Care Unit, Royal Victoria Hospital, Belfast, Northern Ireland, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Shyamsundar", 
        "givenName": "Murali", 
        "id": "sg:person.01027351713.07", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01027351713.07"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Clinical Sciences, Division of Infection Medicine, University of Lund, Lund, Sweden", 
          "id": "http://www.grid.ac/institutes/grid.4514.4", 
          "name": [
            "Department of Clinical Sciences, Division of Infection Medicine, University of Lund, Lund, Sweden"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Herwald", 
        "givenName": "Heiko", 
        "id": "sg:person.01052174740.55", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01052174740.55"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Centre for Infection and Immunity, Queen\u2019s University of Belfast, Belfast, UK", 
          "id": "http://www.grid.ac/institutes/grid.4777.3", 
          "name": [
            "Centre for Infection and Immunity, Queen\u2019s University of Belfast, Belfast, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Dib", 
        "givenName": "Karim", 
        "id": "sg:person.01122242267.14", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01122242267.14"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/nm1001-1123", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050084361", 
          "https://doi.org/10.1038/nm1001-1123"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/cc11353", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043665151", 
          "https://doi.org/10.1186/cc11353"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/89058", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053462083", 
          "https://doi.org/10.1038/89058"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00011-011-0422-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008924911", 
          "https://doi.org/10.1007/s00011-011-0422-6"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1745-6215-13-170", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053650185", 
          "https://doi.org/10.1186/1745-6215-13-170"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2013-07-19", 
    "datePublishedReg": "2013-07-19", 
    "description": "BackgroundHeparin-binding protein is released by neutrophils during inflammation and disrupts the integrity of the alveolar and capillary endothelial barrier implicated in the development of acute lung injury and systemic organ failure. We sought to investigate whether oral administration of simvastatin to patients with acute lung injury reduces plasma heparin-binding protein levels and improves intensive care unit outcome.MethodsBlood samples were collected from patients with acute lung injury with 48 h of onset of acute lung injury (day 0), day 3, and day 7. Patients were given placebo or 80 mg simvastatin for up to 14 days. Plasma heparin-binding protein levels from patients with acute lung injury and healthy volunteers were measured by ELISA.ResultsLevels of plasma heparin-binding protein were significantly higher in patients with acute lung injury than healthy volunteers on day 0 (p\u2009=\u20090.011). Simvastatin 80 mg administered enterally for 14 days reduced plasma level of heparin-binding protein in patients. Reduced heparin-binding protein was associated with improved intensive care unit survival.ConclusionsA reduction in heparin-binding protein with simvastatin is a potential mechanism by which the statin may modify outcome from acute lung injury.Trial registrationCurrent controlled trials: ISRCTN70127774", 
    "genre": "article", 
    "id": "sg:pub.10.1186/1471-2466-13-47", 
    "isAccessibleForFree": true, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.2784459", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1024955", 
        "issn": [
          "1471-2466"
        ], 
        "name": "BMC Pulmonary Medicine", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "13"
      }
    ], 
    "keywords": [
      "acute lung injury", 
      "lung injury", 
      "heparin-binding protein", 
      "healthy volunteers", 
      "heparin-binding protein levels", 
      "intensive care unit survival", 
      "intensive care unit outcomes", 
      "capillary endothelial barrier", 
      "systemic organ failure", 
      "protein levels", 
      "organ failure", 
      "MethodsBlood samples", 
      "plasma levels", 
      "oral administration", 
      "unit survival", 
      "patients", 
      "day 3", 
      "day 7", 
      "injury", 
      "day 0", 
      "simvastatin", 
      "plasma heparin", 
      "endothelial barrier", 
      "unit outcomes", 
      "potential mechanisms", 
      "heparin", 
      "volunteers", 
      "outcomes", 
      "ConclusionsA reduction", 
      "days", 
      "placebo", 
      "statins", 
      "inflammation", 
      "levels", 
      "protein", 
      "neutrophils", 
      "ResultsLevels", 
      "ELISA", 
      "administration", 
      "trials", 
      "survival", 
      "onset", 
      "failure", 
      "disrupts", 
      "reduction", 
      "barriers", 
      "mechanism", 
      "samples", 
      "development", 
      "integrity"
    ], 
    "name": "Simvastatin decreases the level of heparin-binding protein in patients with acute lung injury", 
    "pagination": "47", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1019469490"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/1471-2466-13-47"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "23870614"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/1471-2466-13-47", 
      "https://app.dimensions.ai/details/publication/pub.1019469490"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-10-01T06:38", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221001/entities/gbq_results/article/article_601.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1186/1471-2466-13-47"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/1471-2466-13-47'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/1471-2466-13-47'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/1471-2466-13-47'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/1471-2466-13-47'


 

This table displays all metadata directly associated to this object as RDF triples.

250 TRIPLES      21 PREDICATES      99 URIs      86 LITERALS      26 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/1471-2466-13-47 schema:about N1a25fde460af43b69f6627330f0d520a
2 N4721f928d83b414dbc44f8724ac56e98
3 N4f9042c7d76d42489b918ea8e7323ee4
4 N573dc19e10c1405b8530637b2be6224d
5 N575320e8042b4f81a6ae2b1e6bf987df
6 N5caa714639f649498c660b5ac02b3edf
7 N6918ae2aa8af4c168b1d2b9117748699
8 Nae78959540ef4bbf8a70293f291fffe0
9 Naee8babb37e448af800e272bd52d0ec3
10 Nb48372580c5240178ef39af1de625982
11 Nb9d170e5c2df4f839224d44f2edc214a
12 Nc3eee952091a4795b3c750498bae0529
13 Ncb7f33f2171946faa737e47cc8f9983b
14 Nd078b64017a94e41ab8f9e3fe3652e0b
15 Nd8ac17e8b0104ebfaa5147cc0ccfb01b
16 Ne7235cf516c74853b19d803875757ec8
17 Neb79a79decc141538fe2d3501583ef82
18 Nf51ab6abdee9403189d94184b3d75e10
19 Nfb8b3300b97547a1a2b5ae240ac90d1b
20 anzsrc-for:11
21 anzsrc-for:1103
22 schema:author Nb92daa7695084a568ff9178c0569a490
23 schema:citation sg:pub.10.1007/s00011-011-0422-6
24 sg:pub.10.1038/89058
25 sg:pub.10.1038/nm1001-1123
26 sg:pub.10.1186/1745-6215-13-170
27 sg:pub.10.1186/cc11353
28 schema:datePublished 2013-07-19
29 schema:datePublishedReg 2013-07-19
30 schema:description BackgroundHeparin-binding protein is released by neutrophils during inflammation and disrupts the integrity of the alveolar and capillary endothelial barrier implicated in the development of acute lung injury and systemic organ failure. We sought to investigate whether oral administration of simvastatin to patients with acute lung injury reduces plasma heparin-binding protein levels and improves intensive care unit outcome.MethodsBlood samples were collected from patients with acute lung injury with 48 h of onset of acute lung injury (day 0), day 3, and day 7. Patients were given placebo or 80 mg simvastatin for up to 14 days. Plasma heparin-binding protein levels from patients with acute lung injury and healthy volunteers were measured by ELISA.ResultsLevels of plasma heparin-binding protein were significantly higher in patients with acute lung injury than healthy volunteers on day 0 (p = 0.011). Simvastatin 80 mg administered enterally for 14 days reduced plasma level of heparin-binding protein in patients. Reduced heparin-binding protein was associated with improved intensive care unit survival.ConclusionsA reduction in heparin-binding protein with simvastatin is a potential mechanism by which the statin may modify outcome from acute lung injury.Trial registrationCurrent controlled trials: ISRCTN70127774
31 schema:genre article
32 schema:isAccessibleForFree true
33 schema:isPartOf N27abca92de3847a6afbfd933fbd32149
34 Nbdd8cbb773e7403b831f445b717f2c8d
35 sg:journal.1024955
36 schema:keywords ConclusionsA reduction
37 ELISA
38 MethodsBlood samples
39 ResultsLevels
40 acute lung injury
41 administration
42 barriers
43 capillary endothelial barrier
44 day 0
45 day 3
46 day 7
47 days
48 development
49 disrupts
50 endothelial barrier
51 failure
52 healthy volunteers
53 heparin
54 heparin-binding protein
55 heparin-binding protein levels
56 inflammation
57 injury
58 integrity
59 intensive care unit outcomes
60 intensive care unit survival
61 levels
62 lung injury
63 mechanism
64 neutrophils
65 onset
66 oral administration
67 organ failure
68 outcomes
69 patients
70 placebo
71 plasma heparin
72 plasma levels
73 potential mechanisms
74 protein
75 protein levels
76 reduction
77 samples
78 simvastatin
79 statins
80 survival
81 systemic organ failure
82 trials
83 unit outcomes
84 unit survival
85 volunteers
86 schema:name Simvastatin decreases the level of heparin-binding protein in patients with acute lung injury
87 schema:pagination 47
88 schema:productId N74bf7a8ccfc142ffa27c8d712f0f580e
89 Na3134fc82dc84e36a21ee0cad73d8793
90 Ndecb3871a6b94b2b8170d591e4e9a027
91 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019469490
92 https://doi.org/10.1186/1471-2466-13-47
93 schema:sdDatePublished 2022-10-01T06:38
94 schema:sdLicense https://scigraph.springernature.com/explorer/license/
95 schema:sdPublisher Nb4f5971a48394209843e5ad96e8018d7
96 schema:url https://doi.org/10.1186/1471-2466-13-47
97 sgo:license sg:explorer/license/
98 sgo:sdDataset articles
99 rdf:type schema:ScholarlyArticle
100 N010736fbc36446f9a74b579bf54765af rdf:first sg:person.01052174740.55
101 rdf:rest N2a022be2ec004693bae1d3c092afb8d7
102 N1a25fde460af43b69f6627330f0d520a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
103 schema:name Acute Lung Injury
104 rdf:type schema:DefinedTerm
105 N1fd1661fca5b4174a610bcbd732a1c54 rdf:first sg:person.01266220671.16
106 rdf:rest Nbdc4821cc89142b8aa26e60770dbcf36
107 N27abca92de3847a6afbfd933fbd32149 schema:volumeNumber 13
108 rdf:type schema:PublicationVolume
109 N2a022be2ec004693bae1d3c092afb8d7 rdf:first sg:person.01122242267.14
110 rdf:rest rdf:nil
111 N4721f928d83b414dbc44f8724ac56e98 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
112 schema:name Antimicrobial Cationic Peptides
113 rdf:type schema:DefinedTerm
114 N49b105d28bcd4e4bb00ce484548c9f96 rdf:first sg:person.0706061252.72
115 rdf:rest N1fd1661fca5b4174a610bcbd732a1c54
116 N4f9042c7d76d42489b918ea8e7323ee4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
117 schema:name Middle Aged
118 rdf:type schema:DefinedTerm
119 N573dc19e10c1405b8530637b2be6224d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
120 schema:name Treatment Outcome
121 rdf:type schema:DefinedTerm
122 N575320e8042b4f81a6ae2b1e6bf987df schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
123 schema:name Aged
124 rdf:type schema:DefinedTerm
125 N5caa714639f649498c660b5ac02b3edf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
126 schema:name Female
127 rdf:type schema:DefinedTerm
128 N6918ae2aa8af4c168b1d2b9117748699 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
129 schema:name Blood Proteins
130 rdf:type schema:DefinedTerm
131 N74bf7a8ccfc142ffa27c8d712f0f580e schema:name pubmed_id
132 schema:value 23870614
133 rdf:type schema:PropertyValue
134 Na3134fc82dc84e36a21ee0cad73d8793 schema:name doi
135 schema:value 10.1186/1471-2466-13-47
136 rdf:type schema:PropertyValue
137 Nae78959540ef4bbf8a70293f291fffe0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name Dose-Response Relationship, Drug
139 rdf:type schema:DefinedTerm
140 Naee8babb37e448af800e272bd52d0ec3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
141 schema:name Double-Blind Method
142 rdf:type schema:DefinedTerm
143 Nb48372580c5240178ef39af1de625982 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Carrier Proteins
145 rdf:type schema:DefinedTerm
146 Nb4f5971a48394209843e5ad96e8018d7 schema:name Springer Nature - SN SciGraph project
147 rdf:type schema:Organization
148 Nb92daa7695084a568ff9178c0569a490 rdf:first sg:person.013052706317.18
149 rdf:rest N49b105d28bcd4e4bb00ce484548c9f96
150 Nb9d170e5c2df4f839224d44f2edc214a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
151 schema:name Male
152 rdf:type schema:DefinedTerm
153 Nbdc4821cc89142b8aa26e60770dbcf36 rdf:first sg:person.01027351713.07
154 rdf:rest N010736fbc36446f9a74b579bf54765af
155 Nbdd8cbb773e7403b831f445b717f2c8d schema:issueNumber 1
156 rdf:type schema:PublicationIssue
157 Nc3eee952091a4795b3c750498bae0529 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
158 schema:name Adult
159 rdf:type schema:DefinedTerm
160 Ncb7f33f2171946faa737e47cc8f9983b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
161 schema:name Hydroxymethylglutaryl-CoA Reductase Inhibitors
162 rdf:type schema:DefinedTerm
163 Nd078b64017a94e41ab8f9e3fe3652e0b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
164 schema:name Humans
165 rdf:type schema:DefinedTerm
166 Nd8ac17e8b0104ebfaa5147cc0ccfb01b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
167 schema:name Intensive Care Units
168 rdf:type schema:DefinedTerm
169 Ndecb3871a6b94b2b8170d591e4e9a027 schema:name dimensions_id
170 schema:value pub.1019469490
171 rdf:type schema:PropertyValue
172 Ne7235cf516c74853b19d803875757ec8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
173 schema:name Administration, Oral
174 rdf:type schema:DefinedTerm
175 Neb79a79decc141538fe2d3501583ef82 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
176 schema:name Prospective Studies
177 rdf:type schema:DefinedTerm
178 Nf51ab6abdee9403189d94184b3d75e10 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
179 schema:name Simvastatin
180 rdf:type schema:DefinedTerm
181 Nfb8b3300b97547a1a2b5ae240ac90d1b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
182 schema:name Survival Rate
183 rdf:type schema:DefinedTerm
184 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
185 schema:name Medical and Health Sciences
186 rdf:type schema:DefinedTerm
187 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
188 schema:name Clinical Sciences
189 rdf:type schema:DefinedTerm
190 sg:grant.2784459 http://pending.schema.org/fundedItem sg:pub.10.1186/1471-2466-13-47
191 rdf:type schema:MonetaryGrant
192 sg:journal.1024955 schema:issn 1471-2466
193 schema:name BMC Pulmonary Medicine
194 schema:publisher Springer Nature
195 rdf:type schema:Periodical
196 sg:person.01027351713.07 schema:affiliation grid-institutes:grid.416232.0
197 schema:familyName Shyamsundar
198 schema:givenName Murali
199 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01027351713.07
200 rdf:type schema:Person
201 sg:person.01052174740.55 schema:affiliation grid-institutes:grid.4514.4
202 schema:familyName Herwald
203 schema:givenName Heiko
204 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01052174740.55
205 rdf:type schema:Person
206 sg:person.01122242267.14 schema:affiliation grid-institutes:grid.4777.3
207 schema:familyName Dib
208 schema:givenName Karim
209 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01122242267.14
210 rdf:type schema:Person
211 sg:person.01266220671.16 schema:affiliation grid-institutes:grid.416232.0
212 schema:familyName Craig
213 schema:givenName Thelma R
214 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01266220671.16
215 rdf:type schema:Person
216 sg:person.013052706317.18 schema:affiliation grid-institutes:grid.4777.3
217 schema:familyName McAuley
218 schema:givenName Daniel F
219 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013052706317.18
220 rdf:type schema:Person
221 sg:person.0706061252.72 schema:affiliation grid-institutes:grid.4777.3
222 schema:familyName O’Kane
223 schema:givenName Cecilia M
224 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0706061252.72
225 rdf:type schema:Person
226 sg:pub.10.1007/s00011-011-0422-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008924911
227 https://doi.org/10.1007/s00011-011-0422-6
228 rdf:type schema:CreativeWork
229 sg:pub.10.1038/89058 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053462083
230 https://doi.org/10.1038/89058
231 rdf:type schema:CreativeWork
232 sg:pub.10.1038/nm1001-1123 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050084361
233 https://doi.org/10.1038/nm1001-1123
234 rdf:type schema:CreativeWork
235 sg:pub.10.1186/1745-6215-13-170 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053650185
236 https://doi.org/10.1186/1745-6215-13-170
237 rdf:type schema:CreativeWork
238 sg:pub.10.1186/cc11353 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043665151
239 https://doi.org/10.1186/cc11353
240 rdf:type schema:CreativeWork
241 grid-institutes:grid.416232.0 schema:alternateName Regional Intensive Care Unit, Royal Victoria Hospital, Belfast, Northern Ireland, UK
242 schema:name Regional Intensive Care Unit, Royal Victoria Hospital, Belfast, Northern Ireland, UK
243 rdf:type schema:Organization
244 grid-institutes:grid.4514.4 schema:alternateName Department of Clinical Sciences, Division of Infection Medicine, University of Lund, Lund, Sweden
245 schema:name Department of Clinical Sciences, Division of Infection Medicine, University of Lund, Lund, Sweden
246 rdf:type schema:Organization
247 grid-institutes:grid.4777.3 schema:alternateName Centre for Infection and Immunity, Queen’s University of Belfast, Belfast, UK
248 schema:name Centre for Infection and Immunity, Queen’s University of Belfast, Belfast, UK
249 Regional Intensive Care Unit, Royal Victoria Hospital, Belfast, Northern Ireland, UK
250 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...